About usSign in
Status
ACTIVE
Global HQ
France
Countries of investment
  • France
Investment stages
  • Seed
Industries
  • BioTechnology
  • Health tech
  • Artificial Intelligence
  • Fintech
About
Bios Partners is a venture capital firm specializing in biotechnology, life sciences, and medical devices. They leverage extensive industry expertise to support companies from early stages through commercialization.
Min check size
$100K
Max check size
$2M
Fund size
NPS

Investment Thesis

Bios Partners aims to disrupt geographic favoritism by investing in highimpact biotech companies in underinvested regions. They focus on advanced science in overlooked areas to bring transformative healthcare solutions to market.
Lead investor
Co Invest
Number of exits
Preferred contact method

Team

Stuart Smith – Cofounder and Partner

Aaron Fletcher

Ph.D. – Cofounder and Partner

Emily Roberts – Partner

Savanna McAlester – Associate

Portfolio

410 Medical

Actuate Therapeutics

Azitra

Cognition Therapeutics

Encore Vision

iLumen Scientific

Immusoft Corporation

IN8bio

Lantern Pharma

Lung Therapeutics

ONL Therapeutics

Opus Genetics

SIRPant Immunotherapeutics

Stream Biomedical

Taysha Gene Therapies

Trefoil Therapeutics

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp